LATEST PUBLICATIONS
In vitro diagnostics (IVD) is the technique utilized to diagnose and detect diseases, conditions, and infections using biological samples such as blood, urine, stool, tissues, and other body fluids, derived from the human body. These tests are performed especially in standalone laboratory, and hospital-based laboratory. In addition, IVD finds application in detection of various diseases such as cancer, diabetes and others. Also, it is used in the pregnancy detection as selfcare tests. The North America IVD market accounted $20,886 million ...
September 2017 | $5370 |View Details>>
In vitro diagnostic is a non-invasive technique utilized in early diagnosis and management of diseases. The In vitro diagnostic offers detection of several diseases, and helps in management and maintenance of diseases related conditions. IVD are reagents, instruments, and systems intended to diagnose various diseases that include determination of the state of health, and also cure, mitigate, treat, or prevent diseases. The Europe IVD market accounted for $19,124 million in 2016, and is estimated to reach $26,623 million by 2023, growing at a CAGR of 4.7% during the analysis period of 2017–2023.
September 2017 | $5370 |View Details>>
Ulcerative colitis (UC) is an inflammatory gastrointestinal disease that affects colon or large intestine. UC is characterized as an incurable disease with low mortality rate and is generally diagnosed in adolescence and early adulthood. As per NCBI, about 1.86 billion patients were diagnosed with UC globally in 2014, with 1.54 billion patients currently receiving treatment. Moreover, it is estimated that in 2015, there were 2.1 million diagnosed cases of UC in U.S., Japan, and five major European countries namely Germany, ...
September 2017 | $5370 |View Details>>
The 2017-2022 Bio Pharma Buffer Report on Global and United States Market, Status and Forecast, by Players, Types and Applications is a professional and in-depth study on the current state of the Bio Pharma Buffer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The global market for Bio Pharma Buffer is expected to reach about 929.47 Million USD by 2022 from 595.63 Million USD in ...
September 2017 | $2960 |View Details>>
China Vitamin D Testing Market Research Report 2017
In the last several years, China market of Vitamin D Testing developed rapidly, with an average growth rate of 17.90%. In 2016, China Revenue of Vitamin D Testing is nearly 80.68 M USD, will continue growth at 16.01% in 2022 the market of Vitamin D Testing will at 196.66 M USD. This report studies the Vitamin D Testing development status and future trend in China, focuses on top players in China, also splits Vitamin D Testing by type and by applications, ...
September 2017 | $3200 |View Details>>